Cerebrotendinous xanthomatosis: a literature review and case study
Frontiers in Cardiovascular Medicine · 09.12.2024 · 11
DOI: 10.3389/fcvm.2024.1496442 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 09.12.2024. Verfasst von Anthony Matta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Civilian Hospitals of Colmar, Colmar, France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cerebrotendinous xanthomatosis (CTX) is a rare but treatable inherited neurometabolic disorder that can lead to severe sequelae if left untreated. Chenodeoxycholic acid is a safe and effective treatment for CTX. Early diagnosis is essential to improve patient outcomes. Neurological disturbances, cataracts, and intractable diarrhea are key features to raise diagnostic suspicion and differentiate CTX from other metabolic disorders in patients with dyslipidemia and xanthomas. The diagnosis of CTX depends on high cholestanol plasma levels, undetectable plasma bile acids, neuroradiological findings, and CYP27A1 gene analysis. This review provides a stepwise approach to diagnosing patients with CTX, aims to improve physician awareness of CTX, and highlights the effectiveness of chenodeoxycholic acid as the standard of care. In addition, we report a unique case of CTX with major premature cardiovascular events, initially misdiagnosed as heterozygous familial hypercholesterolemia. This review also provides evidence to establish the c.470T>C (p. Leu157Pro) variant of the CYP27A1 gene as a likely pathologic variant.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Civilian Hospitals of Colmar, Colmar, France.
- School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
- INSERM, UMR1214 Toulouse NeuroImaging Centre "TONIC," Centre Expert Parkinson de Toulouse, Service de Neurologie, CHU de Toulouse, Toulouse, France.
- Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Paul Sabatier, Laboratoire de Biochimie, Institut Fédératif de Biologie, CH…
- Department of Neuroradiology, Toulouse University Hospital, Toulouse, France.
- Department of Cardiology, INSERM UMR 1295, Toulouse University Hospital, Toulouse, France.
Zitieren
APA
Matta, A., Ory Magne, F., Levade, T., Bonneville, F., & Ferrières, J. (2024). Cerebrotendinous xanthomatosis: a literature review and case study. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1496442
Vancouver
Matta A, Ory Magne F, Levade T, Bonneville F, Ferrières J. Cerebrotendinous xanthomatosis: a literature review and case study. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1496442
BibTeX
@article{Matta2024,
author = {Matta, Anthony and Ory Magne, Fabienne and Levade, Thierry and Bonneville, Fabrice and Ferrières, Jean},
title = {Cerebrotendinous xanthomatosis: a literature review and case study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1496442}
}
EUVIMED